3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
10
Unknown
7
Not yet recruiting
5
Terminated
4
Completed
3
Active not recruiting
3
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Head and Neck Neoplasms
1
Interventions
Cisplatin
4
130-nm albumin-bound paclitaxel
3
camrelizumab
2
Oxaliplatin
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Laparoscopy
2
Bevacizumab
2
trilaciclib
1
trastuzumab deruxtecan
1
toripalimab
1
selinexor
1
sacituzumab govitecan
1
ribociclib
1
olaparib
1
nimotuzumab
1
lenvatinib
1
fluorodopa F 18
1
durvalumab
1
decitabine and cedazuridine drug combination
1
dalpiciclib
1
cemiplimab
1
carfilzomib
1
apatinib
1
anlotinib
1
abemaciclib
1
Valacyclovir
1
Temozolomide
1
Taxes
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Enrolling by invitation
×
Platinum Compounds
×
Clear all
NCT07618624
2026-06-01
BRIDGE
Sun Yat-sen University
Phase 2
Enrolling by invitation
42 enrolled